提升社会排斥群体疫苗接种率的干预措施:一项系统综述
该系统综述纳入20项研究(18项随机对照试验和2项非随机研究),评估提升社会排斥群体疫苗接种率的干预效果。荟萃分析显示加速乙肝疫苗接种程序(OR:1.45,95%CI:1.10-1.91)和财政激励(OR:5.36,95%CI:2.61-11.01)可能有益,证据确信度为中等。其他干预措施效果证据不明确,结论受限于高质量研究缺乏。
要点
- 加速乙肝疫苗接种程序可能提升接种率(OR:1.45,95%CI:1.10-1.91),证据确信度中等。
- 财政激励可能大幅提升接种率(OR:5.36,95%CI:2.61-11.01),证据确信度中等。
- 其他干预措施效果证据不明确,整体研究质量有限。
核心结论
- 加速乙肝疫苗接种程序和财政激励可能提升社会排斥群体的疫苗摄取,证据确信度为中等。
- 其他类型干预措施的效果证据尚无定论,结论受限于高质量研究缺乏。
研究设计与样本
- 系统综述纳入随机对照试验和非随机干预研究,检索MEDLINE、Embase和PsycINFO至2025年1月。
- 共筛选2673条记录,最终纳入20项研究(18项随机对照试验和2项非随机研究)。
- 偏倚风险评估采用Cochrane偏倚风险工具。
- 数据分析采用随机效应荟萃分析和效应方向图。
主要发现
- 多数研究(13项)在药物使用人群中开展,16项研究调查乙肝疫苗接种率。
- 干预类型包括:加速乙肝疫苗接种程序(6项)、财政激励(4项)、教育措施(2项)、动机性访谈(2项)、产后家访(1项)、强化外展和现场接种(1项),以及4项作为护理协调或护士引导病例管理模型组成部分的不同干预。
- 9项研究为高偏倚风险,6项存在一些担忧,5项为低偏倚风险。
- 荟萃分析显示加速接种程序可能有益(OR:1.45,95%CI:1.10-1.91),财政激励可能有益(OR:5.36,95%CI:2.61-11.01),两者证据确信度均为中等。
- 其他类型干预措施的有效性证据尚无定论。
关键数值与推荐
- 加速乙肝疫苗接种程序:OR:1.45,95%CI:1.10-1.91,证据确信度中等。
- 财政激励:OR:5.36,95%CI:2.61-11.01,证据确信度中等。
临床怎么用
- 在药物使用人群等社会排斥群体中,可考虑采用加速乙肝疫苗接种程序提升接种率。
- 财政激励可作为提升疫苗接种率的潜在策略,但需结合具体人群和背景。
- 其他干预措施的效果证据不明确,实施时应结合本地数据和评估。
局限性
- 缺乏高质量研究限制了结论的可靠性。
- 多数研究集中在药物使用人群和乙肝疫苗,结果外推受限。
- 9项研究为高偏倚风险,6项存在一些担忧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are known inequalities in vaccine uptake and the distribution of vaccine-preventable diseases. Understanding the best ways to increase vaccine uptake among socially excluded groups is vital to reduce these inequalities. AIM: To assess the effectiveness of interventions to increase vaccine uptake among socially excluded groups. METHODS: Systematic review of randomised controlled trials (RCTs) and non-randomised studies of interventions. Studies were eligible if they evaluated an intervention to increase uptake of any vaccination on the World Health Organization immunisation schedule and focused on socially excluded populations (e.g. people experiencing homelessness, people who use drugs). MEDLINE, Embase and PsycINFO were searched to January 2025. Risk of bias was assessed using Cochrane risk of bias tools. Data were analysed using random-effects meta-analyses and effect direction plots. RESULTS: Of 2673 records, 20 studies were eligible (18 RCTs and two non-randomised studies). Most (13 studies) were conducted among people who use drugs and investigated hepatitis B (HBV) vaccination uptake (16 studies). Various interventions were identified: accelerated HBV vaccination schedules (six studies); financial incentives (four); educational initiatives (two); motivational interviewing (two); post-natal home visits (one); enhanced outreach and on-the-spot vaccination (one), and four varying interventions delivered as part of care co-ordination or nurse-guided case management models. Nine studies were at high risk of bias, six had some concerns and five were at low risk. Meta-analyses indicated a potential beneficial effect of accelerated schedules (odds ratio (OR):1.45, 95%CI:1.10-1.91) and financial incentives (OR:5.36, 95%CI:2.61-11.01). Confidence in the evidence was judged to be 'moderate' for both these interventions. Evidence for the effectiveness of other types of interventions was inconclusive. CONCLUSION: We identify some promising strategies for improving uptake of vaccinations among some socially excluded groups. The conclusions that can be drawn are, however, limited by the lack of high-quality studies on the topic.
引用
- Sidebotham E, Caldwell DM, Davies SR, et al. Interventions to increase vaccine uptake among socially excluded groups: A systematic review. Vaccine. 2026. PMID: 41666790. doi:10.1016/j.vaccine.2026.128314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。